All-trans retinoic acid-induced hypothalamus–pituitary–adrenal hyperactivity involves glucocorticoid receptor dysregulation

Clinical reports have highlighted a role for retinoids in the etiology of mood disorders. Although we had shown that recruitment of the nuclear receptor retinoic acid receptor-α (RAR-α) to corticotropin-releasing hormone (CRH) promoter is implicated in activation of the hypothalamus–pituitary–adrena...

Full description

Saved in:
Bibliographic Details
Published in:Translational psychiatry 2013-12, Vol.3 (12), p.e336-e336
Main Authors: Hu, P, Liu, J, Zhao, J, Qi, X-R, Qi, C-C, Lucassen, P J, Zhou, J-N
Format: Article
Language:English
Subjects:
631/443/319/367
692/420
692/699/476/1414
Animals
Behavior, Animal - drug effects
Behavioral Sciences
Biological Psychology
Corticosterone - metabolism
Corticosterone - secretion
Corticotropin-Releasing Hormone - drug effects
Corticotropin-Releasing Hormone - metabolism
Depression - chemically induced
Depression - metabolism
Dexamethasone - pharmacology
Feedback, Physiological - drug effects
Glucocorticoids - pharmacology
Hormone Antagonists - pharmacology
Hydrocortisone - metabolism
Hypothalamo-Hypophyseal System - drug effects
Hypothalamo-Hypophyseal System - metabolism
Medicine
Medicine & Public Health
Mifepristone - pharmacology
Neurosciences
Original
original-article
Paraventricular Hypothalamic Nucleus - drug effects
Paraventricular Hypothalamic Nucleus - metabolism
Pharmacotherapy
Pituitary-Adrenal System - drug effects
Pituitary-Adrenal System - metabolism
Psychiatry
Rats
Receptors, Glucocorticoid - antagonists & inhibitors
Receptors, Glucocorticoid - drug effects
Receptors, Glucocorticoid - metabolism
Receptors, Retinoic Acid - metabolism
Retinoic Acid Receptor alpha
Signal Transduction
Tretinoin - adverse effects
Tretinoin - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinical reports have highlighted a role for retinoids in the etiology of mood disorders. Although we had shown that recruitment of the nuclear receptor retinoic acid receptor-α (RAR-α) to corticotropin-releasing hormone (CRH) promoter is implicated in activation of the hypothalamus–pituitary–adrenal (HPA) axis, further insight into how retinoids modulate HPA axis activity is lacking. Here we show that all- trans retinoic acid (RA)-induced HPA activation involves impairments in glucocorticoid receptor (GR) negative feedback. RA was applied to rats chronically through intracerebroventricular injection. A 19-day RA exposure induced potent HPA axis activation and typical depression-like behavior. Dexamethasone failed to suppress basal corticosterone (CORT) secretion, which is indicative of a disturbed GR negative feedback. In the hypothalamic paraventricular nucleus, increased CRH + and c-fos + cells were found while a negative R−2 + /ER + correlation was present between the number of RAR-α + and GR + cells. This was paralleled by increased RAR-α and decreased GR protein expression in the hypothalamus. Additional in vitro studies confirmed that RA abolished GR-mediated glucocorticoid-induced suppression of CRH expression, indicating a negative cross-talk between RAR-α and GR signaling pathways. Finally, the above changes could be rapidly normalized by treatment with GR antagonist mifepristone. We conclude that in addition to the ‘classic’ RAR-α-mediated transcriptional control of CRH expression, disturbances in GR negative feedback constitute a novel pathway that underlies RA-induced HPA axis hyperactivity. The rapid normalization by mifepristone may be of potential clinical interest in this respect.
ISSN:2158-3188
2158-3188
DOI:10.1038/tp.2013.98